Patent · US Active

Peptide nucleic acid based guanidinium compounds

US8309514B2 · kind B2 · utility

6Cited by

2References

15Claims

0Family size

Assignee

NITTO DENKO CORPORATION · JP

Inventors

Gang Zhao · Oceanside, US
Chieko Kitaura · Osaka, JP
Jian Liu · Los Angeles, US
Lei Yu · Huangguan, CN

Key dates

Filing date	Mar 4, 2010
Grant date	Nov 13, 2012
Priority date	—
Expiry date	Dec 10, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are transmembrane transporter compounds containing guanidinium groups to enhance transport across biomembranes. Therapeutic and other biologically active moieties may be attached to the compounds. The transmembrane transporter compounds may include peptide nucleic acid monomer units.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.